BPC-157

Promoted for joint, tendon, and gut healing. Preclinical animal data is strong; human evidence is very limited (~3 small studies). Removed from FDA Category 2 in April 2026; PCAC review scheduled July 2026 — not yet formal Category 1 and not FDA-approved.

• Peptides for Recovery & Joint Health: BPC-157 Explained

  BPC-157 is one of the most-discussed recovery peptides. Here's what the research shows, what the 2026 FDA changes mean, and an honest look at the evidence gaps.

• Compounded vs. Research Peptides: What's Legal and What's Safe in 2026

  The difference between a compounded peptide prescription and a gray-market 'research' peptide is the difference between regulated and unregulated. Here's what changed in 2026.

• How Much Does Peptide Therapy Cost?

  A realistic breakdown of what peptide therapy costs — consults, the peptides themselves, bloodwork, and why insurance generally won't cover it.

• Peptides for Perimenopause: What the Research Actually Says

  A grounded look at peptides discussed for perimenopause — GH-axis peptides, BPC-157, kisspeptin, collagen — and where the evidence is strong versus preliminary.

• What Are Peptides? A Woman's Guide to Hormone & Wellness Peptides

  A clear, evidence-based guide to peptides for women — what they are, which ones have real research behind them, and what to know before considering peptide therapy.

• Solace MD

  Higher price band, faster shipping, more personal care — the right fit if cost isn't the primary constraint.

  4.6/5

• Evergreen Women's Health

  Strongest fit for perimenopausal women seeking continuity of care — pairs hormone testing with peptide protocols.

  4.5/5

• Northstar Peptide Co.

  Specialty: recovery and skin peptides. Less hormone-focused than competitors, but a tighter, more specialized catalog.

  4.2/5

See the full provider comparison for all peptides side by side.